Survey and Research Archives | Page 19 of 98 | Be Korea-savvy

Archive by category Survey and Research

KFSH&RC Leads Global Healthcare Revolution with AI and Robotics

KFSH&RC Leads Global Healthcare Revolution with AI and Robotics

RIYADH, Saudi Arabia, June 27, 2024 (Korea Bizwire) – King Faisal Specialist Hospital & Research Centre (KFSH&RC) is at the forefront of the global AI and robotics revolution. These technological advancements, driven by Saudi Vision 2030, are set to unlock an estimated $15 billion to $27 billion in economic value for the Kingdom’s medical sector [...]

Freshworks Report Reveals AI Is Delivering Strong Productivity Gains and Unlocking Higher-Value Work for Employees

Freshworks Report Reveals AI Is Delivering Strong Productivity Gains and Unlocking Higher-Value Work for Employees

More than half of knowledge workers are actively using AI at work—and driving efficiencies of nearly 24 business days of work per year SAN MATEO, Calif., June 27, 2024 (Korea Bizwire) – Freshworks Inc. (NASDAQ: FRSH) released its new Global AI Workplace Report today, revealing how various workplace departments are interacting with AI since the new era of generative [...]

Valeura Energy Inc.: Precautionary Suspension of Wassana Production

Valeura Energy Inc.: Precautionary Suspension of Wassana Production

SINGAPORE, June 27, 2024 (Korea Bizwire) – Valeura Energy Inc. (TSX:VLE, OTCQX:VLERF) (“Valeura” or the “Company”) announces the suspension of production at its 100% owned Wassana field, offshore Gulf of Thailand.  During a scheduled underwater inspection of the field’s production facility, the mobile offshore production unit Ingenium (the “MOPU”), a crack was identified within one of the [...]

Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery

Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery

DURHAM, N.C., June 27, 2024 (Korea Bizwire) – Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the launch of its artificial intelligence (AI) Innovation Studio, signaling a strategic investment in reshaping the execution of clinical trials today and into the future. The studio will develop and deploy AI and machine learning [...]

Transforming Cancer Care: Novotech Releases Report on Radiopharmaceuticals Global Clinical Trials Landscape

Transforming Cancer Care: Novotech Releases Report on Radiopharmaceuticals Global Clinical Trials Landscape

BOSTON, Jun. 26 (Korea Bizwire) – Novotech, an internationally renowned full-service clinical Contract Research Organization (CRO) known for its collaboration with biotech firms to accelerate the development of innovative therapeutics across all phases, has today published a leading industry report, Radiopharmaceuticals – Global Clinical Trial Landscape. Over the past 25 years cancer treatment has evolved significantly, incorporating [...]

Survey Reveals Accountants Play Vital Role In Driving Financial Transformation for Organizations

Survey Reveals Accountants Play Vital Role In Driving Financial Transformation for Organizations

With mounting bandwidth concerns and urgency to provide critical insights, 60% of accountants and CFOs still do not consider financial transformation a top priority LOS ANGELES, June 26, 2024 (Korea Bizwire) – Today, FloQast, a Finance and Accounting Operations Platform provider created by accountants for accountants, announced the results of its latest survey, Embracing Financial Transformation: What [...]

Samsung Bioepis Releases 2024 Sustainability Report, Highlighting Progress in Accessibility and R&D Innovation

Samsung Bioepis Releases 2024 Sustainability Report, Highlighting Progress in Accessibility and R&D Innovation

Report highlights key progress and achievements across three pillars: access to medicines, R&D innovation, and product quality and patient safety 430,000 patients have been treated with Samsung Bioepis’ biosimilars across 40 countries in 2023 In 10 countries, our biosimilars have created social impact worth approximately 2.5 trillion KRW (1.9 billion USD) in 2023 The company [...]

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Advanced TNBC

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Advanced TNBC

SHANGHAI, June 25, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (NMPA) has approved the supplemental new drug application (sNDA) for toripalimab (product code: JS001) in [...]

FreedomPay and Toast Survey Reveals Top Priorities for Enterprise Hospitality Leaders: Data Security, Integration, and Growth Enablement

FreedomPay and Toast Survey Reveals Top Priorities for Enterprise Hospitality Leaders: Data Security, Integration, and Growth Enablement

Integration and Customer Support Emerge as Crucial Factors in Merchant Preferences for Payment Solutions Philadelphia, Pennsylvania, June 25, 2024 (Korea Bizwire) – A recent survey conducted by FreedomPay, a global leader in Next Level Commerce™ solutions, in collaboration with Toast, a leading cloud-based restaurant management software company, has unveiled crucial insights into the top priorities for enterprise hospitality [...]

Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic EXBLIFEP® in Gulf Cooperation Council countries and South Africa

Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic EXBLIFEP® in Gulf Cooperation Council countries and South Africa

Acino gains commercial rights for EXBLIFEP® (cefepime/enmetazobactam) within the member states of the Gulf Cooperation Council (GCC) and South Africa. EXBLIFEP® has been approved by the U.S. Food and Drug Administration (FDA) and the European Commission (EC) for the treatment of severe infections earlier in 2024. Saint-Louis, France and Weil am Rhein, Germany and Zurich, [...]